Formation Bio Deal History & Licensing Activity
Formation Bio is a life sciences. Over the past three years, Formation Bio has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (4 deals). The company currently has 1 active clinical trial, primarily in Immunology.
Deals (12mo)
1
Active Trials
1
Top Modality
Small Molecules
Focus Area
Immunology
Formation Bio Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Formation Bio in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| gusacitinib | Sanofi | Small Molecules | Phase 3 | license | Jun 2025 |
| TYK2 inhibitor | Lynk Pharmaceuticals | Small Molecules | Unknown | collaboration | Jun 2025 |
Formation Bio Pipeline Focus
Therapeutic areas and modalities where Formation Bio is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Formation Bio Clinical Pipeline
Formation Bio has 1 active clinical trial across 1 development phase.
1
Phase 1
See How Your Asset Matches Formation Bio's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Formation Bio Licensing & Deal Activity
Formation Bio is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Formation Bio ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Formation Bio include Immunology (2 deals and trials), and Codev Deals (2 deals and trials). In terms of modality, Formation Bio has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Formation Bio and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Formation Bio's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.